GoodRx Gold (GDRX) - Forward P/S Multiple

Brandmark of goodrx.com (GDRX)

The current forward P/S ratio reflects market expectations for GoodRx Holdings, Inc. (GDRX). Investors value the high scalability of an IT model that incurs no logistics costs. Dominance is sustained through the control of pricing data and influence over pharmacy commissions. The environmental footprint remains minimal due to the digital nature of operations. The value of 0.20 represents the current metric, determining the extent to which business value is priced relative to future sales.

GDRX GoodRx: Market Cap to Future Revenue Ratio in the range 07/04/2022 - 11/17/2026

GoodRx Holdings, Inc. - analytical breakdowns and key metrics (GDRX)

- stock price and consensus target price:
Comprehensive company analysis:GDRX (GoodRx Holdings, Inc.)
Product sample of GoodRx Gold

GoodRx Holdings, Inc. (GDRX) possesses high scalability, yet margin stagnation driven by pharmacy algorithms limits its operating leverage. The expected price-to-sales ratio digitizes this trend, benchmarking current market capitalization against projected sales volume. This metric measures the extent of the market's overvaluation of future flows, revealing either investment attractiveness or the risk of a systemic slowdown in expansion. Analysis of this chart allows for the determination of the fair value point for a mature software business.

Competitor analysis for GoodRx Holdings, Inc.

Price-to-Projected Revenue Ratio Veeva Corp VEEV|Price to Expected Revenue Ratio DOCS (Doximity, Inc.)|HQY: Forward Price-to-Revenue Multiple|Forward Price to Sales WAY (waystar.com)|CorVel Corp. (CRVL) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Privia Health (PRVA)|Price-to-Projected Revenue Ratio Huron Corp|Market Cap to Projected Revenue CERT (Certara Corp)|Price-to-Projected Revenue Ratio Omnicell (OMCL)|SDGR (Schrödinger) - Forward Price to Sales|Phreesia Inc - Forward Price-to-Revenue Multiple|Forward Price to Sales OMDA|Evolent - Forward P/S Multiple|Forward Price to Sales HSTM (HealthStream Corp)|DH (Definitive Healthcare Inc.) - Forward Price-to-Revenue Multiple|Consensus Cloud Solutions (CCSI) - Forward P/S Multiple|Price-to-Projected Revenue Ratio agilon health|Market Cap to Projected Revenue ABSI (Absci Corporation)|Forward P/S Multiple SY|NRC (National Research Corp) - Forward Price to Sales|Forward P/S Multiple SPOK (spok.com)|Forward Price to Sales OPRX|trubridge.com - Forward P/S Multiple|SLP (Simulations Plus) - Market Cap to Projected Revenue|SOPHiA GENETICS SA (SOPH) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Health Catalyst, Inc.|Forward Price-to-Revenue Multiple CCLD|researchsolutions.com (RSSS) - Market Cap to Expected Sales Ratio|Forward P/S Multiple DLHC|OneMedNet Corp - Market Cap to Projected Revenue|Forward P/S Multiple SCNX (Scienture Corp)|Price to Expected Revenue Ratio HCTI (Healthcare Triangle Corp)|iSpecimen Corp - Forward P/S Multiple|Forward Price to Sales BFRG (bullfrogai.com)|WORX: Forward P/S Multiple|Forward Price-to-Revenue Multiple MSP Recovery|Price-to-Projected Revenue Ratio icoreconnect.com|MEDS: Forward Price to Sales|Price-to-Projected Revenue Ratio Orgenesis Inc. (ORGS)|Market Cap to Expected Sales Ratio R1 RCM, Inc.|Forward P/S Multiple SHCR (sharecare.com)|Market Cap to Expected Sales Ratio Streamline Health Solutions, Inc. (STRM)|SYRA - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio Apollo Medical Holdings Inc. AMEH|Model N (MODN) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue NXGN